China News Service, June 16-According to a Reuters report on the 15th, a negotiation document shows that Brazil plans to purchase 60 million doses of China's Cansino Biotech Co., Ltd.'s new crown vaccine, which will be delivered in the third and fourth quarters of 2021.
Last week, Brazilian Health Minister Marcelo Ceroga told the Senate committee investigating the handling of Brazil’s new crown epidemic that the government is seeking to purchase new vaccines to promote diversification of vaccination supplies.
He revealed at the time that he might buy China's Cansino new crown vaccine.
Data Map: On January 18, the first batch of vaccinators in Brazil were vaccinated against China.
According to reports, Cansino new crown vaccine is an adenovirus vector vaccine jointly developed by the Academy of Military Medicine of the Chinese Academy of Military Sciences and Cansino Company.
At present, this vaccine has obtained emergency use licenses in Mexico, Pakistan, Hungary, Chile, Argentina and other countries.
In 2020, China's Cansino Bio-New Crown Vaccine has carried out Phase III clinical trials in Argentina.
According to the report released by the health agency that conducted the test in Argentina, the storage condition of the vaccine is 2-8 degrees Celsius, which is very conducive to storage and transportation. No volunteers participating in the test have reported adverse reactions.
According to reports, on June 15, local time, the Brazilian Ministry of Health stated that in the past 24 hours, there were 80,609 new confirmed cases of new crowns in the country, with a total of 17.53 million confirmed cases; 2468 new deaths and a total of 490,696 deaths.
In order to contain the epidemic, the Brazilian authorities have approved the emergency use of the British AstraZeneca vaccine and the Chinese Coxing vaccine, and vaccination has been launched nationwide.